450 related articles for article (PubMed ID: 24290098)
1. Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?
Hui TC; Pua U
J Vasc Interv Radiol; 2014 Jan; 25(1):41-6. PubMed ID: 24290098
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors.
Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM
J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099
[TBL] [Abstract][Full Text] [Related]
3. Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
Somma F; Stoia V; Serra N; D'Angelo R; Gatta G; Fiore F
PLoS One; 2019; 14(5):e0216935. PubMed ID: 31141552
[TBL] [Abstract][Full Text] [Related]
4. Change in portal vein hemodynamics after chemoembolization for hepatocellular carcinoma: evaluation through multilevel dynamic multidetector computed tomography during arterial portography.
Murotani K; Nakai M; Sato M; Minamiguchi H; Sonomura T; Hosokawa S; Nishioku T
J Comput Assist Tomogr; 2015; 39(3):396-400. PubMed ID: 25700229
[TBL] [Abstract][Full Text] [Related]
5. Discrepant imaging findings of portal vein thrombosis with dynamic computed tomography and computed tomography during arterial portography in hepatocellular carcinoma: possible cause leading to inappropriate treatment selection.
Toyoda H; Kumada T; Tada T; Mizuno K; Kobayashi N; Inukai Y; Takeda A; Sone Y
Clin J Gastroenterol; 2017 Apr; 10(2):163-167. PubMed ID: 28181172
[TBL] [Abstract][Full Text] [Related]
6. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
Kim GA; Shim JH; Yoon SM; Jung J; Kim JH; Ryu MH; Ryoo BY; Kang YK; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
J Vasc Interv Radiol; 2015 Mar; 26(3):320-9.e6. PubMed ID: 25612807
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.
Silva JP; Berger NG; Tsai S; Christians KK; Clarke CN; Mogal H; White S; Rilling W; Gamblin TC
HPB (Oxford); 2017 Aug; 19(8):659-666. PubMed ID: 28552299
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Hepatocellular Carcinoma with Tumor Thrombus with the Use of Iodine-125 Seed Strand Implantation and Transarterial Chemoembolization: A Propensity-Score Analysis.
Zhang ZH; Zhang W; Gu JY; Liu QX; Ma JQ; Liu LX; Wang JH; Luo JJ; Yan ZP
J Vasc Interv Radiol; 2018 Aug; 29(8):1085-1093. PubMed ID: 29754851
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
[TBL] [Abstract][Full Text] [Related]
10. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
[TBL] [Abstract][Full Text] [Related]
11. Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial.
Oliveira Ribeiro MC; Moda KA; Alvarez M; Koga KH; Moriguchi SM; Carvalho FC; Pinheiro RSN; Qi X; Romeiro FG
Acad Radiol; 2024 May; 31(5):1839-1848. PubMed ID: 38016824
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.
Georgiades CS; Hong K; D'Angelo M; Geschwind JF
J Vasc Interv Radiol; 2005 Dec; 16(12):1653-9. PubMed ID: 16371532
[TBL] [Abstract][Full Text] [Related]
13. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
14. Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein.
Luo J; Yan Z; Liu Q; Qu X; Wang J
J Vasc Interv Radiol; 2011 Apr; 22(4):479-89. PubMed ID: 21463757
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
[TBL] [Abstract][Full Text] [Related]
16. Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma.
Vogl TJ; Nour-Eldin NE; Emad-Eldin S; Naguib NN; Trojan J; Ackermann H; Abdelaziz O
World J Gastroenterol; 2011 Mar; 17(10):1267-75. PubMed ID: 21455325
[TBL] [Abstract][Full Text] [Related]
17. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.
Chung JW; Park JH; Han JK; Choi BI; Han MC
AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547
[TBL] [Abstract][Full Text] [Related]
19. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma.
Golfieri R; Mosconi C; Cappelli A; Giampalma E; Galaverni MC; Pettinato C; Renzulli M; Monari F; Angelelli B; Pini P; Terzi E; Ascanio S; Garzillo G; Piscaglia F; Bolondi L; Trevisani F
Future Oncol; 2015; 11(23):3133-42. PubMed ID: 26467398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]